Table 3.
Cases with ≥2 SCSC | Controls | OR | 95% CI | |
---|---|---|---|---|
AZA | ||||
No | 78 (87.6) | 306 (94.4) | 1.00 | Referent |
Yes | 11 (12.4) | 18 (5.6) | 5.17 | 1.54–17.3 |
MPA | ||||
No | 35 (39.3) | 89 (27.5) | 1.00 | Referent |
Yes | 54 (60.7) | 235 (72.5) | 0.50 | 0.28–0.90 |
Cyclosporine | ||||
No | 40 (44.9) | 184 (56.8) | 1.00 | Referent |
Yes | 49 (55.1) | 140 (43.2) | 1.22 | 0.67–2.23 |
Tacrolimus | ||||
No | 56 (62.9) | 161 (49.7) | 1.00 | Referent |
Yes | 33 (37.1) | 163 (50.3) | 0.74 | 0.39–1.41 |
Odds Ratio Estimates are generated from conditional logistic regression models that condition on the matched sets and also included the following covariates: age at transplant and transplant hospital
Numbers and percentages for cases reported out of study participants with non-missing information on number of multiple SCSC (N=132)